Building upon the success of the African Cancer Researchers Travel Awards, the American Association for Cancer Research is pleased to announce the expansion of this award program and to invite eligible applicants from all low-, lower-middle, and middle-income economy countries (LMIC).Read More
This past April, the American Association for Cancer Research welcomed its 2018 class of African Cancer Researchers Travel Award (ACRTA) recipients to its Annual Meeting. Established in 2016, these travel awards provide financial assistance to meritorious early-career investigators engaged in cancer research in Africa, allowing them to attend and present their research at the AACR Annual Meeting.Read More
Each month, the American Association for Cancer Research (AACR) publishes 10 articles from its eight esteemed scientific journals, showcasing some of the leading discoveries in cancer research. Read on to learn about the editors’ selections from this month. All articles featured are freely available for a limited time.Read More
For many aspiring investigators, pursuing a career in cancer research can be a complex exploration of self and purpose.
In this touching and inspiring piece published in The New York Times, a former AACR Undergraduate Scholar Awardee, Mya Roberson, now a doctoral student at the University of North Carolina Gillings School of Global Public Health, shares how her participation in the AACR Annual Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved helped her realize the meaning in her research.Read More
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party with a Purpose, a Philadelphia gala that raises funds for cancer …Read More
Cancer cells ingest copious amounts of the simple sugar glucose. This addiction may hold the key to how cancer can be treated.Read More
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to treat 10 different types of cancer, in addition to solid tumors located anywhere in the body that have certain DNA damage and repair-related biomarkers. However, only a small percentage of patients respond to these treatments, and they can have significant side effects. Researchers are looking for biomarkers that can identify patients who are likely to respond to immune checkpoint inhibitors.Read More
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving career his native Nigeria, studying African ethnomedicine in the management, prevention, and control of cancer and diabetes.Read More
Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well a drug targets a disease, the majority of this research is funded by the National Institutes of Health (NIH). So, on September 14, 2017, hundreds of people from 37 states and Washington, D.C., from over 300 institutes and organizations, gathered for the 5th Annual Rally for Medical Research with a common messageRead More
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino physician work force dropped from 135 to 105 physicians per 100,000, according to a study by the Center for the Study of Latino Health and Culture at the University of California, Los Angeles.
This decline is alarming. It means that the growing Latino population does not get culturally competent care needed to improve patient health outcomes.Read More